SCI Immunol: scientists found the first cell scorch inhibitor, or it can treat inflammatory diseases
-
Last Update: 2018-08-26
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
August 26, 2018 / bioin / - inflammatory cell death disorder is the main cause of many inflammatory diseases Cell Scorch is a highly inflammatory cell death process, which will use the holes generated in the cell to disrupt the electrolyte balance of the cell, leading to cell death Gasdermin D is the pore forming effector protein in the process of cell scorching, which can control the cell membrane cracking and the release of highly inflammatory molecules (such as interleukin-1 β), which will aggravate the over activation of innate immune response But so far, no drugs have been found that can disrupt the charring of cells Photo source: Science immunology recently, researchers from the medical school of Case Western Reserve University and Cleveland Clinic found that necrosulfonamide is a direct chemical inhibitor of gasdermin D, which can directly combine with gasdermin D, thus inhibiting cell scorch Relevant research results were published in science immunology recently, entitled "chemical disruption" of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis”。 In a sepsis animal model, the researchers found that necrosulfonamide can effectively inhibit the death of pyrolytic cells This suggests that gasdermin D inhibitors may be effective in the treatment of inflammatory diseases Reference materials: rathkey et al, chemical disruption of the psychological pore forming protein gasdermin D inbits informational cell death and sepsis, science Immunology (2018) Doi: 10.1126/scientific.aat2738
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.